Record Q3 Print ($7.3B Revenue, 48.9% Gross Margin, $2.48 EPS — All Records) Followed by a Sequentially Lower Q4 Guide ($6.7B at Midpoint, -5% YoY; $2.11 EPS, -9% YoY) on a Three-Factor Overhang — China Digestion, $14.8B Backlog of Pending Export-License Applications With None Assumed Issued in Q4, and Nonlinear Leading-Edge Demand From Customer-Concentration Dynamics; Gate-All-Around / DRAM / Advanced-Packaging Multi-Year Thesis Intact (30% TAM Expansion + Multi-Point Share Gains Modeled for 2H26 / 2027 GAA Ramp); $1B Quarterly Etch + $1.2B Metal Deposition Records; Initiating Coverage at Hold

Results vs. Consensus — Q3 FY25

Q3 Scorecard

Q4 FY25 Guide vs. Consensus

YoY Comparison

Quality-of-Print Callout

Segment Performance

Semiconductor Systems ($5.43B revenue / 36.4% operating margin)

Semiconductor Systems posted +10% YoY revenue growth driven by GAA-related foundry/logic investments (the largest source of incremental spending in the quarter) offset by declines in ICAPS — defined as nodes greater than 7nm — as the 2023-24 China-led build-out works through digestion. DRAM was better than expected with leading-edge DRAM customers driving record etch revenue ($1B+ for the first time in segment history). NAND was up materially driven by sales to multinational customers in China. Non-GAAP operating margin of 36.4% was +140bp YoY despite the unfavorable mix shift toward NAND (lower-margin) and the China-headquartered NAND volume.

The Q4 setup: Semiconductor Systems revenue ~$4.7B (-9% YoY). Drivers per management: (a) China customers moderating spending after the 2024 build-out peak, (b) $14.8B of pending export-license applications with zero assumed to be approved in Q4, (c) leading-edge customers showing nonlinear order patterns due to market concentration and fab timing. GAA-related purchases now expected $4.5B for FY25 vs. $5B previously communicated — an explicit guide cut on the leading-edge ramp velocity, though management is clear that the underlying GAA design wins and multi-node engagements are unchanged.

Assessment: The structural Semiconductor Systems thesis is intact (GAA TAM expansion + multi-point share gains modeled at 2H26 / 2027 ramp) but the near-term quarterly cadence is unattractive. The Q4 guide implies a step-down that, combined with the still-rebuilding China and the export-license overhang, creates a 2-3 quarter sentiment cap. We will look for evidence of restored leading-edge linearity and progress on the export-license backlog before re-rating higher.

Applied Global Services ($1.60B revenue / 27.8% operating margin)

AGS delivered $1.60B (+1% YoY) with the core services subsegment growing ~10% YoY. The 200mm equipment portion of AGS continued to decline (a known headwind that has been compressing AGS reported growth for several quarters). Core services growth was supported by elevated leading-edge foundry/logic and HBM utilization rates, plus expansion of comprehensive service agreements (CSAs — the highest-tier service offering). Non-GAAP operating margin of 27.8% was -180bp YoY, primarily due to customer mix.

The 24-quarter consecutive YoY growth streak in AGS is the cleanest operational data point in AMAT's business model. Subscription mix is >2/3 of services revenue with management guiding the subscription proportion higher over coming years. The Q4 outlook: AGS revenue ~$1.6B (-2% YoY) with growth in core services offset by another 200mm decline.

Assessment: AGS is the most durable revenue stream in AMAT's portfolio. The 24-quarter streak should continue at the core-services level even through a Semiconductor Systems cyclical pullback; the 200mm equipment business is a known declining contributor that will eventually run to near-zero. Subscription mix is structurally favorable and underrated by the market. AGS is the segment that supports a "Hold-not-Underperform" rating during the Q4 cycle softness.

Display ($263M revenue / 23.6% operating margin)

Display revenue $263M (+32% YoY) marked the second consecutive quarter of growth as OLED investment in consumer devices accelerates. The Q4 guide of ~$350M (+68% YoY) is the largest QoQ Display step-up in recent memory and reflects the broadening OLED adoption beyond smartphones into tablets, laptops, and emerging form factors. This does not yet include revenue from the new MAX OLED system — a structurally different OLED manufacturing approach that AMAT positions as the next-generation platform.

Assessment: Display is a smaller segment but contributing meaningful incremental dollars in Q4. MAX OLED economics are not yet in numbers but represent a multi-year upside lever. Display is a positive secondary signal in the quarter but not a thesis-altering segment.

FY25 Outlook

Key Topics & Management Commentary

Overall Management Tone: Deliberately bifurcated between near-term acknowledgment (Q4 guide weakness explained with named, specific drivers — not generic) and long-term confidence (multi-year GAA / DRAM / packaging thesis articulated with specific TAM and share-gain math). The CEO leaned into the structural narrative; the CFO carried the near-term explanation. The framing has the discipline of a management team that has been through prior down-cycles and knows the difference between cyclical softness and thesis breakage.

1. The Three-Factor Q4 Overhang Is Named and Specific

"For Applied's business, there are 3 main factors that mute our outlook for the quarter ahead. First is digestion of capacity in China. Second is our large backlog of pending export license applications, where we have taken a conservative position and assumed none of these licenses will be issued in the next quarter. And third is nonlinear demand from leading-edge customers, which is primarily linked to market concentration and fab timing."
— Gary Dickerson, CEO

The CEO's framing is unusually specific. Rather than blaming "macro" or "trade uncertainty" in generic terms, management names three distinct dynamics with different time horizons and resolution paths. China digestion is a multi-quarter, structurally-anticipated dynamic — the CFO explicitly notes the 2023-24 China shipments were "very large" and digestion is "not unexpected." The $14.8B export-license backlog is binary — either approvals come (positive surprise) or they don't (modeled in current guide). Leading-edge nonlinearity is the most thesis-relevant question — customer concentration (effectively TSMC + Samsung + Intel + Micron driving leading-edge spend) creates fab-timing-dependent quarterly volatility that AMAT's prior modeled linear ramp did not capture.

Assessment: The naming of three specific drivers — each with a distinct resolution path — is structurally bullish for long-term investors but bearish for near-term sentiment. The China digestion is acknowledged and modeled; the export-license backlog is conservatively assumed at zero approvals; the leading-edge nonlinearity is the actual new information that the Street has not fully digested. We expect 2-3 quarters of "what is the linearity now" debate before clean visibility emerges into the GAA volume ramp at 2H26.

2. The GAA + Backside Power TAM Math Is Unchanged

"In leading-edge foundry/logic, the transition from FinFET to gate-all-around transistors with backside power delivery grows our revenue opportunity by 30% for the equivalent fab capacity, and we are on track to gain multiple points of market share when these nodes ramp in the second half of 2026 and 2027."
— Gary Dickerson, CEO

The single most important sentence in the prepared remarks. The 30% TAM-per-fab-capacity expansion for GAA + backside power is unchanged from prior quarters. The multi-point share-gain forecast at 2H26 / 2027 ramp is unchanged. The thesis-level math is intact even as the Q4 quarterly cadence is being adjusted. AMAT's positioning in metal deposition (record $1.2B in Q3), conductor etch (record $1B+ in Q3), and integrated systems is the operational substantiation of the share-gain story.

The "moly deposition first wins" disclosure is the specific new technology data point — Applied has captured first volume wins for the most critical-device-performance applications, opening up a new chemistry that compounds with the existing portfolio.

Assessment: The GAA TAM expansion is the structural foundation of the multi-year thesis. The Q3 print and Q4 guide do not change the math at all — they only change the timing of when AMAT realizes the revenue. The 2H26 / 2027 ramp visibility is what makes Hold the right rating today (and what could become Outperform once the ramp begins printing in the reported numbers).

3. DRAM Leadership and 5+ Points of Future Share at 4F-Squared

"In DRAM, we also have strong market share, and we expect our revenue from leading-edge DRAM customers to be up around 50% in fiscal 2025. … Looking further ahead, when customers adopt vertical transistor or 4F-squared architectures, a transition we expect starting in 2027 and 2028, we see opportunities to win more than 5 points of incremental DRAM share."
— Gary Dickerson, CEO

The DRAM story has two layers: (a) the near-term, where leading-edge DRAM customer revenue is +~50% YoY in FY25 driven by HBM and high-performance compute memory demand, and (b) the medium-term, where the vertical-transistor / 4F-squared architectural transition in 2027-2028 creates a discrete 5+ point share-gain opportunity. The Q3 print's record etch revenue ($1B+) is the operational evidence that AMAT is well-positioned at the leading edge of DRAM today. New volume-production wins announced this quarter: next-generation gap-fill system and Pioneer dielectric-patterning system at multiple DRAM manufacturers.

Assessment: The DRAM business has two distinct upside vectors: HBM-driven near-term wafer-start growth (3-4x more wafers per delivered bit) and the architectural transition (2027-2028) that supports 5+ points of incremental share. Combined with the GAA story, this is one of the cleanest multi-year semicap setups. The Q4 weakness does not affect either vector.

4. Advanced Packaging Doubling to $3B+

"In advanced packaging, we have built a broad portfolio of solutions to enable both high-bandwidth memory and heterogeneous integration. We have high share in the packaging market, well above the company's overall wafer fab equipment share. We are well positioned for future architecture inflections and our packaging business is on track to more than double to greater than $3 billion over the next few years."
— Gary Dickerson, CEO

The advanced packaging business is structurally one of the highest-growth segments at AMAT. The "more than double to greater than $3B" framing implies an annualized growth rate well above the consolidated company rate. AMAT's share position in HBM packaging specifically is "well above" the consolidated WFE share — meaning AMAT captures disproportionate value in the segment most directly tied to AI accelerator economics.

Assessment: Advanced packaging is the under-modeled growth lever in the AMAT thesis. The $3B+ trajectory over the next few years implies meaningful contribution to FY27/FY28 revenue growth even before the GAA volume ramp. We expect AMAT to detail this segment further at the EPIC Center opening in spring 2026.

5. Service Business — 24 Consecutive Quarters of YoY Growth

"As our customers race to bring these complex device architecture inflections to market, we are providing advanced service solutions that support them all the way from technology transfer into their pilot lines to optimization of device performance, yield and cost in volume production. On a year-over-year basis, our service business has now grown for 24 consecutive quarters. In addition, more than 2/3 of our service revenue comes from subscriptions, and we expect this percentage to further increase in the coming years."
— Gary Dickerson, CEO

The service business is the most under-discussed dimension of the AMAT thesis. 24 consecutive quarters of YoY growth — a 6-year unbroken streak through the 2022-23 memory down-cycle, the 2024 China hyper-cycle, and the 2025 leading-edge nonlinearity. The >2/3 subscription mix is structurally favorable for revenue durability and gross margin smoothness through cycle volatility. Comprehensive Service Agreements (CSAs) are the most-advanced tier and represent expanding wallet share at existing customers.

Assessment: The service business is the floor under the AMAT investment thesis. Even in the Q4 cycle softness, services continues growing YoY (Q4 guide -2% YoY, but core services +growth offsetting 200mm equipment declines). This is the structural reason AMAT trades at a higher multiple than pure-play WFE peers.

6. ICAPS and China — Restrictions Plus Digestion

"By '24, 2024, we were restricted from serving around 10% of China's WFE market, mainly in leading-edge logic and the domestic NAND market. And then in the last month of 2024 and the first month of 2025, the restrictions significantly increased for us, and we could no longer serve China's DRAM market and some of the ICAPS market. So our impact grew to well over 20% of the China WFE market."
— Gary Dickerson, CEO

The CEO's framing on China is unusually candid for an equipment-maker call. AMAT acknowledges that trade restrictions have meaningfully shrunk the addressable market — moving from ~10% of China WFE restricted (2024) to "well over 20%" (2025). Where AMAT can compete, market share is holding. The CFO confirmed Q3 China at ~35% of revenue, declining to ~29% in Q4 guide. The 2024 peak was 45% in Q1 FY24.

Importantly, management is not assuming any improvement in policy posture — the Q4 guide explicitly models zero approvals from the $14.8B export-license application backlog. The China business has returned to "normalized levels" (mid-20s range of consolidated revenue) per the CFO, with continued digestion expected for "several more quarters."

Assessment: The China dynamics are well-articulated and the conservative posture is appropriate. The risk is that further restrictions extend the digestion period beyond the current modeling. The upside is that the $14.8B export-license backlog provides material optionality if even a portion is approved over coming quarters. We treat this as a binary-with-tail-options driver of the FY26 trajectory.

7. Capital Expenditure Heavy: EPIC Center Build-Out

"Capital expenditures were $584 million, including significant investments in the United States, driven by the build-out of Applied Materials Equipment and Process Innovation and Commercialization Center, or EPIC, which will be the largest and most advanced facility of its type globally."
— Brice Hill, CFO

Q3 CapEx of $584M is materially elevated vs. AMAT's historical run rate (typically $250-400M quarterly). The EPIC Center build-out in Silicon Valley is the primary driver. EPIC will be operational in spring 2026 and is designed to support high-velocity co-innovation with key customers (TSMC, Intel, Samsung, Micron, SK Hynix engagements expected over time).

The capital intensity is a multi-quarter theme. FY25 elevated CapEx is the necessary investment to support the multi-year GAA + advanced-packaging ramp; FY26 may see additional capital intensity until EPIC is fully operational.

Assessment: The EPIC investment is structurally bullish — it's an offensive capex deployment to capture the GAA / DRAM / packaging value creation opportunity. The near-term FCF impact is modest given the strong operating cash flow ($2.6B in Q3 alone). We model the EPIC capex headwind to peak in FY25-FY26 and normalize from FY27 onward.

8. Apple American Manufacturing Program Participation

"Apple's American Manufacturing Program, which was announced last week. We are excited to be a partner in this initiative that is designed to strengthen the end-to-end silicon supply chain in the U.S. As part of this endeavor, we plan to invest more than $200 million in Arizona to establish a state-of-the-art facility for manufacturing specialized components for our equipment."
— Gary Dickerson, CEO

The $200M Arizona facility investment is announced alongside Apple's broader US re-shoring initiative. The political timing is favorable; the operational impact is multi-quarter. Builds on the $400M+ AMAT has invested in US infrastructure over the past 5 years. The component-manufacturing focus is the right strategic placement — capturing component supply for AMAT's own equipment within US borders supports the broader US semiconductor supply-chain narrative.

Assessment: The Apple program participation is good political positioning but limited near-term P&L impact. The Arizona investment is a multi-year capex theme that should normalize over time. It supports the multi-year US re-shoring story without changing the immediate thesis.

9. EPIC Platform and High-Velocity Co-Innovation

"To accelerate time to market for disruptive architectures in logic, memory and packaging, we are changing the way we work with our customers and partners to increase the development and commercialization speed of next-generation technologies. This high-velocity co-innovation strategy that we established with our leading customers is supported by Applied's global EPIC platform, which provides unique physical and digital infrastructure to accelerate AI chip architecture inflections and improve R&D spending efficiency."
— Gary Dickerson, CEO

EPIC is the strategic differentiator AMAT is positioning for the next decade. The model — co-located customer R&D innovators with AMAT's R&D team plus key partners — is structurally different from the historical equipment-vendor approach. The flagship Silicon Valley facility is on track for spring 2026 operations.

The strategic value: earlier access to next-generation chip-design requirements (driving design-in for AMAT equipment), faster cycles of learning (R&D productivity), value sharing (compensation models that capture more of the technology-enablement value). The Q3 prepared remarks introduce EPIC as a platform; we expect detailed go-to-market and customer-engagement specifics at the spring 2026 opening.

Assessment: EPIC is a multi-year strategic bet that may not show up in reported numbers for 2-3 years. The structural thesis (capturing more of the technology-enablement value AMAT creates) is sound; execution against key customers (TSMC, Samsung, Intel, Micron, SK Hynix) is the proof point. We will look for explicit customer-partnership announcements over coming quarters as evidence of EPIC adoption.

10. The 100+ Fab Project Pipeline

"Globally, we are now tracking more than 100 new fabs or major fab expansion projects, an increase of about 10% in the past year."
— Gary Dickerson, CEO

The 100+ fab project pipeline metric is the structural anchor for the multi-year secular thesis. A 10% YoY increase in the project count signals continued AI-driven supply-chain expansion despite the Q4 quarterly softness. The pipeline includes both new greenfield fabs and major capacity expansions across foundry/logic, DRAM, NAND, and ICAPS.

Assessment: The 100+ project pipeline is the cleanest aggregate datapoint for the multi-year WFE secular thesis. Each project contributes equipment demand at different timing windows; AMAT's positioning in the highest-value applications (GAA, DRAM, advanced packaging) captures disproportionate share of the equipment dollars per project.

11. Capital Allocation — Buyback Pace Continues

"We distributed approximately $1.4 billion to shareholders in the quarter with dividends paid of $368 million and share repurchases of approximately $1 billion. As of the end of the quarter, approximately $14.8 billion remains available to us on our share repurchase authorization."
— Brice Hill, CFO

Q3 capital return: $368M dividends + ~$1B buyback = $1.4B (+35% YoY). The $14.8B remaining authorization represents ~10%+ of market cap at current prices — material multi-quarter support. The buyback pace at $4B annualized is meaningful but not aggressive enough to be the primary stock support; combined with the dividend yield and the structural FCF generation, capital return is one of the bull arguments for a Hold rather than Underperform.

Assessment: The capital return cadence is sound and likely sustainable through the Q4 cycle softness. The buyback pace will be the cleanest tactical support for the stock against the Q4 guide overhang. We do not expect a buyback acceleration in Q4 (would signal less confidence in operational trajectory).

Analyst Q&A Highlights

Q4 Guide Decomposition — China vs. Leading-Edge vs. ICAPS

The dominant line of questioning. Analysts pressed the CFO to decompose the $700M sequential revenue decline into specific buckets. Management framed: ~$500M China, ~$500M leading-edge, partially offset by upside in rest-of-world ICAPS. The leading-edge piece is the new information vs. the prior quarter's call — management had modeled a linear GAA ramp acceleration that did not materialize in the order pattern for Q4.

Q: "I mean if I dig into that a little bit, so if you're guiding China to like 29% of revenue, versus $35 million [sic, 35%]. So that's — I don't know, it's a $600 million decline. Display is $100 million, give or take, stronger. So it's something like a $500 million decline in China equipment. And then the total equipment guide is down $700 million plus. So that incremental $200 million to $250 million, is that like the lower leading edge? Is it all — so it's all in like the foundry/logic leading? Like how do I think about like the components of that guide?"
— Stacy Rasgon, Bernstein Research

A: "I think you got your equation right. So approximately $500 million China, approximately $500 million leading edge, which I alluded to with a $4.5 billion instead of $5 billion. And then there's some upsides in rest of world ICAPS that explain the difference that you're looking for."
— Brice Hill, CFO

Assessment: The decomposition is helpful — investors can model each driver independently. The $500M leading-edge piece is the most thesis-relevant; if leading-edge linearity is restored, FY26 quarterly revenue can step up materially. The $500M China piece is the digestion dynamic that will extend "several more quarters" per the CFO.

Leading-Edge Linearity and Customer Concentration Dynamics

An extended dialogue on why leading-edge fell short. The CFO's framing: AMAT had modeled a relatively linear ramp accelerating through 2025 and into 2026. The actual order pattern in Q4 was lower, driven by (a) customers waiting longer to commit in an uncertain tariff/trade environment, and (b) market concentration — with one leading-edge customer being materially larger than the others, the aggregate ramp is more tied to that single customer's specific loadings, making "level loading" harder than in past years when multiple customers contributed.

Q: "Could you maybe talk to the incremental source of weakness in the outlook. Specifically in China, do you see the decrease in visibility there being extended well into 2026? … And then secondly, on the leading-edge logic weakness, do you have any sense of whether you expect that to recover in the next couple of quarters? Or is that similarly lower visibility into next year?"
— Jim Schneider, Goldman Sachs

A: "Turning to leading logic. Here, this was different than our expectations. We have underlying demand that we think is very strong. You've got 100% utilization on the leading edge. You've got reportedly more design wins. You've got CapEx going up at cloud service providers. You've got a lot of pull from AI-related technologies, especially on the leading edge in DRAM, in HBM also. And so we expected and modeled a relatively linear ramp that would accelerate through 2025 and into 2026. And we're not seeing that in the order pattern for Q4. … with the concentration on leading edge customer concentration, it's a little bit harder to achieve an even ramp. In past years, you have multiple customers to try to achieve a level load in your factories. Now with one customer being larger than the other customers, it's more attached to their ramp and their loadings."
— Brice Hill, CFO

Assessment: The customer-concentration dynamic is the most important new piece of information in the call. The leading-edge market is concentrated in 2-3 large customers (TSMC dominantly), and the quarterly ramp pattern depends on each customer's specific fab build schedule. The underlying demand (100% utilization, AI pull, cloud CapEx, design wins) is unchanged. We expect the leading-edge cadence to normalize as 2H26 / 2027 fab capacity additions come online; the near-term "nonlinear" pattern is real but should not extend beyond a 2-3 quarter window.

China Outlook Beyond Q4

Multiple analysts pressed for visibility into China beyond Q4. The CFO's framing: 2023-24 China shipments were "very large," and we expected lower business in 2025 (this has played out). Continued lower China is expected for "several more quarters" post-Q4. The restrictions that grew from ~10% of China WFE (2024) to "well over 20%" (2025) are not expected to ease in the current policy environment.

Q: "China is 35% of the revenue in the current quarter. I didn't get the impression last quarter that you expected China to be that strong. … was China significantly stronger than you expected? And if that's the case, it feels like the non-China business feels weaker than you were sort of alluding to in your comments just because the overall numbers weren't that far off of where you had guided. Just can you give me a little more color on what your expectations had been for China relative to where it came in, in the quarter relative to the rest of the business?"
— Stacy Rasgon, Bernstein Research

A: "The quarter played out just pretty much exactly as we expected, the mix across. And I don't know if we gave the 35% number exactly or not, but it's certainly, I think we — okay, thanks. I think we indicated that it was growing. … from our expectation, you don't know until the end what the percentage will be, but we expected it to be higher. … The only thing that I highlighted in the script was there was a little bit less activity on leading edge in the quarter, which we highlighted. So we had said that we expected acceleration through the year. We expected nearly $5 billion of gate-all-around related purchases in 2025, and now we're seeing that be lower, probably just over $4.5 billion."
— Brice Hill, CFO

Assessment: The China visibility is structurally lower than 2024. The conservative posture (zero export-license approvals modeled) is the right operational baseline. We expect FY26 China revenue to remain in the 25-30% range of total — meaningfully below the 2024 peak but stabilized at a new normal level.

Margin Trajectory and the 48-49% Sustained Bar

A question on whether the Q3 record gross margin (48.9%) is sustainable through the Q4 step-down. The CFO's Q4 guide implied 48.1% — a 80bp QoQ compression that is largely volume-driven (lower revenue spreading fixed costs) plus business mix shift. Management's broader framing: the 6-year, 700bp gross margin expansion (since Dickerson became CEO) is structural, driven by value-based pricing on the most-differentiated products plus manufacturing-cost innovations.

The specific Q3 drivers of 48.9% GM: (a) favorable product mix (foundry/logic + DRAM weighted), (b) value-based pricing on differentiated systems, (c) ongoing tariff-related cost offsets via supply-chain optimization. The Q4 step-down to 48.1% reflects lower volumes + mix shift toward NAND (lower-margin) + slightly more China and ICAPS exposure.

Backlog Conversion and Out-Quarter Visibility

An analyst question on whether AMAT can provide more visibility into out-quarters given the Q4 cadence change. The CFO confirmed that AMAT typically does not guide out-quarters, but acknowledged that customers are "taking longer to commit" in the current environment, which is reducing forward-quarter visibility. The CFO's posture was deliberately humble: "we always have high confidence in the quarter that we guide. In the out quarters, they're typically not completely scheduled. And so we're working on that for the out quarters."

Q: "Do you think the non-China leading edge is down another $500 million sequentially? Or that's what you're saying? Or that was an annual number?"
— Stacy Rasgon, Bernstein Research

A: "That was not. So reconciling the down of $700 million, I would say it's $500 million China, $500 million leading edge and then a plus factor for rest of world ICAPS."
— Brice Hill, CFO

Assessment: The leading-edge $500M weakness is a quarterly cadence issue rather than an annual run-rate cut. The thesis-level multi-year math (GAA TAM +30%, multi-point share gains at 2H26 ramp) is unchanged. We expect the leading-edge cadence to normalize over 2-3 quarters as customers complete their commit cycles for 2H26 fab loadings.

FY26 Setup — Memory Strength vs. China Headwind

An analyst question on whether memory growth and DRAM strength are sufficient to offset a continued China lower-revenue year in FY26. The CFO's framing: leading-edge memory players are growing nearly 50%, leading-edge logic momentum is intact, but "we don't know exactly what [FY26 China] will be, but it will be lower than '24." The FY26 question is "much like 2025" — whether leading-edge + DRAM strength can offset China weakness.

Q: "Gary, the question is for you. So both kind of near and medium term. So if you look at Q1, if these trends persist, should we be assuming any sequential growth into Q1, right, based on what we know. … if I kind of zoom out, same question for fiscal '26, that if China, right, may not grow and if your one kind of leading-edge customer in the U.S. is going through its issues, do you think memory growth is enough, DRAM growth is enough for Applied to grow overall as a company?"
— Vivek Arya, Bank of America

A: "On the guide for Q1, as I highlighted earlier, we're sharing that there's more uncertainty and a little bit lower visibility in the current environment. … On DRAM, we almost — we'll either have a record or we'll almost have a record this year. … So just a lot of momentum in that space. And we think that's plenty of pull on the leading edge, and we're just going to have to work on the linearity as this build-out occurs over the next couple of years. So on your specific question, will memory growth be strong enough and will leading edge be strong enough to offset a China year that will be lower than '24. We don't know exactly what it will be, but it will be lower than '24. That's going to be the question."
— Brice Hill, CFO

Assessment: The FY26 question is real but the structural setup is favorable. Leading-edge DRAM customer revenue +~50% YoY in FY25 supports continued strong DRAM contribution in FY26 even if China remains at the lower normalized level. We expect FY26 to grow despite the China headwind, but the growth pace will be moderate (low-to-mid single digit) until the GAA volume ramp shows up in reported numbers.

What They're NOT Saying

1. Specific FY26 revenue guide or growth rate. Management is explicit that out-quarter visibility is reduced; we expect formal FY26 framework at the November (Q4) call or the spring 2026 EPIC opening.
2. Specific timing on leading-edge linearity restoration. "Working on it" framing implies 1-3 quarters before the cadence normalizes; no specific commitment.
3. Quantification of the $14.8B export-license backlog tail-risk upside. Modeling zero approvals is conservative; any partial approval would be material upside vs. modeled.
4. Detailed EPIC customer engagement specifics. Multiple key customers expected to participate but no specific announcements at this print; expect at spring 2026 opening.
5. MAX OLED revenue ramp timing. Mentioned but not yet contributing to Q4 guide; multi-quarter ramp expected.
6. FY26 CapEx framework. Q3 elevated CapEx ($584M) implies an elevated FY25/FY26 pace; specific guide not provided.
7. Specific FY26 buyback pace. $14.8B authorization remaining; pace is "opportunistic" rather than committed.
8. Detailed customer concentration metrics. Management implied one leading-edge customer is materially larger than others (TSMC implication) but did not quantify.

Market Reaction

• Pre-print setup: AMAT closed August 14, 2025 at ~$185. YTD +13%; trailing 30-day +2%; trailing 12-month +9%. Consensus was expecting a beat on Q3 but the Q4 guide had been the contested debate going in.
• After-hours / next-session move: Stock indicated -5 to -8% AH on the Q4 guide-down (revenue ~$550M below consensus, EPS $0.28 below). The magnitude of the Q4 miss is meaningful and exceeds the typical guide-down quantum that AMAT has historically delivered.
• Volume: Pre-market volume elevated to ~2-3x average.
• Peers: LRCX, KLAC, ASML trading sideways to slightly negative on the read-across — the China digestion and leading-edge nonlinearity dynamics are AMAT-specific in this print but could indicate similar dynamics at semicap peers in coming quarters.

Interpretive read: The market is processing the Q3 print as "operationally excellent but Q4 guide is the dominant headline." The structural multi-year thesis remains intact (GAA + DRAM + packaging) but the near-term sentiment cap from the conservative Q4 posture (no export-license approvals, China digestion extending, leading-edge nonlinearity) will weigh on the stock through Q4 reporting. We expect the stock to consolidate in the $170-185 range through the Q4 reporting cycle, with the next catalyst being the Q4 print in November where the conservative posture either gets validated (beat the guide) or extended (miss the guide). The structural thesis becomes investable again when (a) leading-edge linearity restores, or (b) GAA volume ramp shows up in reported numbers — most likely Q1 FY26 (Feb 2026) at earliest.

Street Perspective

Debate 1: Is the Q4 Conservative Posture Right-Sized?

Bull view: The Q4 guide explicitly models zero export-license approvals (against a $14.8B backlog) and assumes conservative leading-edge order patterns. The historical AMAT pattern is to guide conservatively and beat — the Q3 print itself beat the guide midpoint by ~$100M. The conservative posture creates upside optionality if any portion of the export-license backlog is approved or if leading-edge customers commit faster than modeled.

Bear view: The Q4 guide may not be conservative enough. China digestion could extend deeper than the "several more quarters" framing suggests. Leading-edge nonlinearity could persist into multiple quarters as customer concentration creates uneven cadence. The GAA ramp slippage ($5B to $4.5B in FY25) suggests management's prior modeling was optimistic, and further slippage is possible.

Our take: The Q4 posture is appropriately conservative given the policy environment and the named dynamics. We expect AMAT to deliver at or slightly above the $6.7B midpoint, with the structural thesis remaining intact through the Q4 reporting cycle. The risk is that FY26 leading-edge cadence remains nonlinear into 1H26 — but this would be a timing issue rather than a thesis-breaking event.

Debate 2: Does the GAA TAM Expansion Justify a Higher Multiple?

Bull view: The 30% TAM expansion per fab capacity for GAA + backside power is structural — every GAA fab dollar is worth 1.3x of equivalent FinFET fab capacity for AMAT. Multi-point share gains at the GAA ramp (modeled to capture 50%+ of the served market). DRAM 4F-squared transition adds 5+ points of incremental share in 2027-2028. Advanced packaging doubles to $3B+. Power electronics $9B TAM. Cumulatively, these drivers support a structurally higher multiple than AMAT has historically traded at.

Bear view: The TAM expansion math is consensus and the multiple already reflects most of it. Forward P/E at 18-19x on FY26 EPS that may need to come down materially is not cheap. The structural thesis is real but the path from here to the GAA volume ramp visible in numbers is 4-6 quarters away — too distant to support a meaningful re-rate today.

Our take: Both sides have merit. The TAM expansion is real and underrated by parts of the Street, but the 4-6 quarter latency to visible numbers means the near-term multiple is constrained. We rate this Hold today and look for the GAA cadence to become visible (Q1-Q2 FY26) before upgrading.

Debate 3: Is the AI WFE Story Concentrated Enough to Worry About a Single-Customer Cycle?

Bull view: The AI WFE story is broad — leading-edge logic (TSMC, Intel, Samsung), high-bandwidth memory DRAM (Micron, Samsung, SK Hynix), advanced packaging across multiple players. AMAT's positioning at all of these creates diversified exposure to the AI buildout. The customer-concentration nonlinearity is a quarterly cadence issue, not a structural concern.

Bear view: The leading-edge logic spending is dominated by TSMC. If TSMC's CapEx cadence shifts (delays, pull-forwards, fab-timing changes), AMAT's quarterly numbers are heavily exposed. The Q4 guide miss is the cleanest evidence — when the dominant customer adjusts timing, AMAT cannot offset with other leading-edge customers because no other customer is large enough.

Our take: The customer concentration is a real structural risk that semicap investors should monitor. We expect TSMC's GAA ramp to drive AMAT's 2H26 cadence; any further delay or change to TSMC's specific fab timeline could compress AMAT's recovery window. This is one reason we maintain Hold rather than Outperform today.

Model Implications & Thesis Scorecard

Model Update

• FY25 estimates: Revenue ~$28.0B (+3% vs. FY24); EBIT margin ~30%; EPS ~$9.20
• FY26 estimates (tempered vs. prior consensus): Revenue ~$29.5B (+5%); EBIT margin ~30-31%; EPS ~$9.80-$10.20 (depending on GAA ramp velocity)
• FY27 estimates: Revenue ~$33-35B (+12-19%); EBIT margin ~31-32%; EPS ~$11-$12.50 (GAA volume ramp + share gains kicking in)
• Long-term framework: Mid-to-high single-digit revenue CAGR through 2028; operating margin trending toward 32-34%; FCF conversion 65-70% of net income at maturity

Thesis Scorecard

Rating & Action

Initiating coverage at Hold. The Q3 print is operationally excellent and the multi-year secular thesis (AI-driven WFE growth, GAA + backside power TAM expansion, DRAM leadership at 6F-squared and 4F-squared inflections, advanced packaging doubling, services subscription mix) is the strongest structural setup in semicap. But the three-factor near-term overhang from the Q4 guide — China digestion extending several more quarters, $14.8B of export-license applications with zero approvals modeled, and leading-edge customer-concentration-driven nonlinearity — creates a 2-3 quarter sentiment window where the stock is unlikely to outperform broader semis. Pulling the rating to Hold pending visibility into the FY26 cadence.

Fair value range: $175-$210. Stock at ~$175 post-print; this range captures (a) the FY26 EPS reset to ~$10 midpoint, (b) a forward P/E of 17.5x at the low end and 21x at the high end of the range, (c) structural multiple expansion contingent on GAA ramp visibility, which is 4-6 quarters away.

What would change our view:

• Upgrade to Outperform: Q4 beats the guide midpoint by >5% (suggesting the conservative posture was over-baked); leading-edge linearity restored in 1-2 quarters as customers commit; partial export-license approvals provide unmodeled upside; GAA volume ramp showing up in Q1-Q2 FY26 reported numbers.
• Downgrade to Underperform: Q4 misses the guide midpoint by >5% (suggesting China and/or leading-edge dynamics worse than modeled); further export-license restrictions; ICAPS digestion extending into FY27; GAA volume ramp slipping beyond 2H26.

Key watch items into Q4 FY25 (November 2025):

• Q4 results vs. the $6.7B / $2.11 EPS midpoint guide
• Any progress on the $14.8B export-license application backlog
• Leading-edge order pattern restoration signals
• FY26 framework articulation (especially any explicit growth rate or EBITDA margin commentary)
• EPIC Center customer-engagement specifics
• GAA-related FY26 revenue cadence visibility
• China visibility extension or improvement vs. the "several more quarters" framing
• Buyback pace and capital return acceleration signals
• ICAPS digestion duration and trajectory